This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
Cacnb2 monoclonal antibody, clone S8b-1
catalog :
MAB7895
quantity :
100 ug
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
S8B-1
The same clone is also sold as:
The same clone is also sold as:
- Rockland Immunochemicals: 200-301-F06
- MyBioSource: MBS190548
- QED Bioscience: 11524
- OriGene: TA309311
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunoprecipitation
product information
catalog id :
MAB7895
product name :
Cacnb2 monoclonal antibody, clone S8b-1
product description :
Mouse monoclonal antibody raised against synthetic peptide of Kcnt1.
clone name :
S8b-1
isotype :
IgG1
gene name :
Cacnb2
gene alias :
Cacnlb2
gene description :
calcium channel, voltage-dependent, beta 2 subunit
immunogen :
A synthetic peptide corresponding to amino acids 189-205 of rat Kcnt1.
protein accession :
NP_446303
form :
Liquid
recommend dilutions :
Western Blot (1-10 ug/mL). Immunohistochemistry (0.1-1.0 ug/mL). Immunocytochemistry (0.1-1.0 ug/mL). Immunofluorescence (1-10 ug/mL). The optimal working dilution should be determined by the end user.
storage buffer :
In PBS, pH 7.4 (50% glycerol, 0.09% sodium azide)
storage instruction :
Store at -20 C. Aliquot to avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Rat
species reactivity cross reactivity :
Human,Mouse,Rat
application key :
WB,IP,IHC
size :
100 ug
autodate :
2010-06-01
updatetime :
2015-05-22 19:36:39
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments